Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marije C Baas

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of Travel Medicine|January 18, 2006
Patterns of imported malaria at the academic medical center, Amsterdam, the NetherlandsMarije C Baas, José C F M Wetsteyn, Tom van Gool
Frontiers in Pharmacology|June 17, 2017
Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the LiteratureCatharina M Mulders-Manders, Marije C Baas, Femke M Molenaar, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 7, 2006
Cystatin C in critically ill patients treated with continuous venovenous hemofiltrationMarije C Baas, Catherine S C Bouman, Frans J Hoek, et al.
Current Medicinal Chemistry|October 5, 2006
N-acetylcysteine and other preventive measures for contrast-induced nephropathy in the intensive care unitMarcus J Schultz, Marije C Baas, Hans P van der Sluijs, et al.
Transplantation Direct|April 14, 2017
Absence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical OutcomeMartijn W F van den Hoogen, Eric J Steenbergen, Marije C Baas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 11, 2010
The value of estimated GFR in comparison to measured GFR for the assessment of renal function in adult patients with Fabry diseaseSaskia M Rombach, Marije C Baas, Ineke J M ten Berge, et al.
Clinical Pharmacokinetics|November 7, 2024
Drug-Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for CliniciansDavid M Burger, Laura Nijboer, Mira Ghobreyal, et al.
Plos One|November 14, 2014
Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapyElena G Kamburova, Hans J P M Koenen, Martijn W F van den Hoogen, et al.
Transplantation|February 13, 2015
Cytokine Release After Treatment With Rituximab in Renal Transplant RecipientsElena G Kamburova, Martijn W F van den Hoogen, Hans J P M Koenen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2014
Combining autologous dendritic cell therapy with CD3 antibodies promotes regulatory T cells and permanent islet allograft acceptanceMarije C Baas, Chantal Kuhn, Fabrice Valette, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of Travel Medicine|January 18, 2006
Patterns of imported malaria at the academic medical center, Amsterdam, the NetherlandsMarije C Baas, José C F M Wetsteyn, Tom van Gool
Frontiers in Pharmacology|June 17, 2017
Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the LiteratureCatharina M Mulders-Manders, Marije C Baas, Femke M Molenaar, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 7, 2006
Cystatin C in critically ill patients treated with continuous venovenous hemofiltrationMarije C Baas, Catherine S C Bouman, Frans J Hoek, et al.
Current Medicinal Chemistry|October 5, 2006
N-acetylcysteine and other preventive measures for contrast-induced nephropathy in the intensive care unitMarcus J Schultz, Marije C Baas, Hans P van der Sluijs, et al.
Transplantation Direct|April 14, 2017
Absence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical OutcomeMartijn W F van den Hoogen, Eric J Steenbergen, Marije C Baas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 11, 2010
The value of estimated GFR in comparison to measured GFR for the assessment of renal function in adult patients with Fabry diseaseSaskia M Rombach, Marije C Baas, Ineke J M ten Berge, et al.
Clinical Pharmacokinetics|November 7, 2024
Drug-Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for CliniciansDavid M Burger, Laura Nijboer, Mira Ghobreyal, et al.
Plos One|November 14, 2014
Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapyElena G Kamburova, Hans J P M Koenen, Martijn W F van den Hoogen, et al.
Transplantation|February 13, 2015
Cytokine Release After Treatment With Rituximab in Renal Transplant RecipientsElena G Kamburova, Martijn W F van den Hoogen, Hans J P M Koenen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2014
Combining autologous dendritic cell therapy with CD3 antibodies promotes regulatory T cells and permanent islet allograft acceptanceMarije C Baas, Chantal Kuhn, Fabrice Valette, et al.
Pageof 4